Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival (Q85348536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

title

Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Le Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Yu Zhu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Huimin An

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Yidong Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Zongming Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Guomin Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

Jiejie Xu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

publication date

18 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

68.e9-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Prognostic factors and selection for clinical studies of patients with kidney cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Activation and regulation of the inflammasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Beneficial and Detrimental Roles of NLRs in Carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

How dying cells alert the immune system to danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Inflammasomes in carcinogenesis and anticancer immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Complex roles of inflammasomes in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Why not treat human cancer with interleukin-1 blockade?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

IL-18 Induces PD-1-Dependent Immunosuppression in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

7 January 2021

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

Biomarkers in personalised treatment of renal-cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.08.008

10.1016/J.UROLONC.2014.08.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25241276 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference